UnitedHealth Group's stock has plunged nearly 50% due to the CEO resignation, withdrawal of guidance, and ongoing legal issues, creating a potential buying opportunity. The stock is deeply oversold with an RSI of 15, trading below both the 200-day and 50-day moving averages, indicating capitulation.

U.S. equities were mixed at midday, with the Dow Jones Industrial Average and S&P 500 slightly higher and the Nasdaq marginally lower.

UnitedHealth Group announced that CEO Andrew Witty is stepping down due to 'personal reasons,' Stephen Hemsley will replace him.

UNH shares plunge impacts 391 ETFs, shaking institutional & retail investors. Explore top ETFs most affected and what's behind the company's downturn.

Wall Street dipped on Thursday as elation from the U.S.-China tariff truce faded for major indexes, while UnitedHealth's stock took a pummeling after a report of a DOJ fraud inquiry into the insurer.

UnitedHealth Group's stock has collapsed nearly 50% in 2025 after a leadership shake-up, surging medical costs, and a DOJ criminal probe into Medicare fraud.

UnitedHealth faces valuation reset amid CEO change, regulatory probes, and cost overruns. Click here for a full analysis of UNH stock.

It created a fandom culture around his accused shooter, Luigi Mangione, and an endless cycle of cheerleading and scolding in response. Prosecutors have prosecuted. Editorial boards have editorialized.